Skip to main content
UniHealth

Doctor search

Grace S Eng, MD

Endocrinology · Emeryville

NPI 1871552679

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
10
2 carriers
Offices
2

Offices

2 locations · University Healthcare Alliance · 334 clinicians in this group

Looking this up.

Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

10 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Eng’s office at (925) 462-7060 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

10 of 10 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026

California Medical Board record

Licence A86467 · Current

Licensed to practise in California · since 2004 · expires 2027-10-31 · University of Michigan Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

4 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
  • Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths130.09 (87.72 to 172.46) · 109 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.274BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.227BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1 (0.06 to 1.94) · 1,209 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.88 (0.6 to 1.16)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.9 · 105 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.8 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 447 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13.7 · 341 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11.2 · 381 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 2,811 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.31) · 7,167 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,659 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.93 (0.92 to 4.94) · 1,668 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.25 (0 to 2.75) · 580 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.67 (1.19 to 4.15) · 1,446 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.17 (0.33 to 12.02) · 633 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths8.11 (4.67 to 11.55) · 619 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.07) · 309 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.39 (0 to 0.96) · 6,085 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.8 · 217 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.724No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.425No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.716No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits12.7 · 416 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.6 · 606 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-30.4 · 359 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-31.8 · 555 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-14.4 · 358 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16 · 382 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.1 (3.2 to 8.2) · 25 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.8 (7.3 to 16) · 25 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.5 · 232 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.9 · 56 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 152 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14.8 (11.1 to 20) · 251 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 579 casesNo differentJan 2024 – Dec 2024

What patients said (535 patients answered, 18% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center
Cleanliness4
Nurse communication3
Doctor communication4
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Alta Bates Summit Medical Center
Room was "always" clean73%
Nurses "always" communicated well75%
Doctors "always" communicated well81%
Staff "always" explained58%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp

Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center - Alta Bates Camp
Clostridium Difficile (C.Diff)Infections0.298BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.18 (0.16 to 2.2) · 730 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.87 (0.51 to 1.23)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths188.12 (132.31 to 243.94) · 50 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths6.8 · 50 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.8 · 41 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.4 · 189 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.6 · 184 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 103 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 1,585 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.4) · 3,929 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.31 (0.11 to 0.51) · 3,954 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.15 (0.95 to 5.36) · 754 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.62 (0 to 3.33) · 325 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.99 (0.39 to 3.59) · 717 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.85 (2.27 to 19.44) · 326 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.79 (1.08 to 8.49) · 302 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.68 (0.19 to 3.18) · 184 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.17 (0 to 0.88) · 3,240 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 161 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.207No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.48No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.785No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.4 · 243 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-58.2 · 194 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-12.3 · 177 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 209 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (3.8 to 7.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.2 (9.4 to 15.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.8 · 150 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.2 · 81 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.4 (10 to 18.1) · 315 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.2) · 137 casesNo differentJan 2024 – Dec 2024

What patients said (449 patients answered, 15% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center - Alta Bates Camp
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Alta Bates Summit Medical Center - Alta Bates Camp
Room was "always" clean62%
Nurses "always" communicated well72%
Doctors "always" communicated well75%
Staff "always" explained53%
Yes, staff "did" give patients this information82%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)58%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand67%
Nurses "always" listened carefully66%
Nurses "always" treated them with courtesy and respect81%
"Always" quiet at night49%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects38%
Yes, staff "did" give patients information about possible symptoms83%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$166,771

Medicare paid this office $166,771 for 413 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)300$48,725$99
Injection, denosumab, 1 mg23$29,002None
Long return visit (40+ min)113$26,956$147
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's343$7,892$14
New patient visit (45+ min)42$4,612$110
See all 10 services
Every Original Medicare service billed
Return visit (30+ min)300$48,725$99
Injection, denosumab, 1 mg23$29,002None
Long return visit (40+ min)113$26,956$147
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's343$7,892$14
New patient visit (45+ min)42$4,612$110
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report57$4,043$29
Short return visit (20+ min)40$2,942$68
New patient visit (60+ min)11$2,017$183
Injection of drug or substance under skin or into muscle29$696$14
Office for the evaluation and management of established patient that may not require presence of healthcare professional13$314$24

Who their Medicare patients are

413 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 10% · Women 79% · Also on Medicaid 10% · Health risk score 1.14. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 62% · Diabetes 35% · Chronic kidney disease 28% · Coronary heart disease 21% · Depression 20% · Atrial fibrillation 18% · Cancer 15% · Heart failure 10% · COPD 10% · Stroke 7% · Dementia 4%.

The office billed $720,908, Medicare allowed $222,231 and paid $166,771; for 7,161 services of 23 kinds; $66,439 of it was for drugs given in the office and $100,332 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244137,161751.14$720,908$166,771
2023375898751.22$271,842$71,304
2022362842741.17$269,162$66,939
2021320874731.37$328,664$73,046
2020278737731.44$274,068$51,004
2019258544731.55$70,946$38,547
2018221440741.49$52,952$30,726
2017186408731.50$81,645$27,655
2016180560731.58$148,213$39,303
2015170788721.53$178,699$50,063
2014176907721.41$187,916$54,380
2013168959731.50$142,737$53,087

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Return visit (30+ min)290$35,135$79
Long return visit (40+ min)123$22,597$114
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report55$4,409$29
New patient visit (45+ min)33$3,594$109
New patient visit (60+ min)22$2,728$124
Short return visit (20+ min)22$1,054$46

2022: 7 services

Original Medicare services billed in 2022
Return visit (30+ min)255$30,843$75
Long return visit (40+ min)126$22,894$119
New patient visit (45+ min)41$3,685$90
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report49$3,605$29
New patient visit (60+ min)23$3,581$156
Short return visit (20+ min)23$1,118$45
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or11$427$28

2021: 8 services

Original Medicare services billed in 2021
Return visit (30+ min)234$31,108$82
Long return visit (40+ min)129$25,399$118
New patient visit (45+ min)41$4,697$115
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report58$4,423$31
New patient visit (60+ min)27$3,826$142
Telephone medical discussion with physician, 21-30 minutes12$1,365$80
Short return visit (20+ min)20$1,228$56
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or13$499$29

2020: 7 services

Original Medicare services billed in 2020
Return visit (30+ min)198$21,233$65
Long return visit (40+ min)89$14,111$93
New patient visit (45+ min)49$5,024$103
Telephone medical discussion with physician, 21-30 minutes43$4,165$72
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report43$3,010$32
Telephone medical discussion with physician, 11-20 minutes16$851$43
Telehealth originating site facility fee11$235$21

2019: 5 services

Original Medicare services billed in 2019
Return visit (30+ min)202$19,301$63
Long return visit (40+ min)81$11,550$93
New patient visit (45+ min)24$2,518$105
New patient visit (60+ min)15$2,261$151
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report28$1,708$32

2018: 5 services

Original Medicare services billed in 2018
Return visit (30+ min)168$16,600$61
Long return visit (40+ min)60$6,848$93
New patient visit (45+ min)37$3,195$86
New patient visit (60+ min)14$1,942$139
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report12$644$31

2017: 3 services

Original Medicare services billed in 2017
Return visit (30+ min)141$14,490$68
Long return visit (40+ min)47$6,301$100
New patient visit (45+ min)34$3,633$107

2016: 6 services

Original Medicare services billed in 2016
Long return visit (40+ min)69$16,405$116
Return visit (30+ min)106$12,791$83
New patient visit (45+ min)22$3,203$146
Short return visit (20+ min)17$1,048$58
Influenza vaccine split virus, preservative free23$932$41
Administration of influenza virus vaccine28$868$30

2015: 6 services

Original Medicare services billed in 2015
Long return visit (40+ min)81$19,436$115
Return visit (30+ min)123$17,501$88
New patient visit (45+ min)16$1,983$124
Short return visit (20+ min)19$1,194$60
Administration of influenza virus vaccine21$631$30
Influenza vaccine split virus, preservative free17$605$36

2014: 7 services

Original Medicare services billed in 2014
Long return visit (40+ min)90$27,410$117
Return visit (30+ min)88$14,945$89
New patient visit (45+ min)17$2,475$146
Short return visit (20+ min)14$927$58
Administration of influenza virus vaccine32$897$28
Influenza vaccine split virus, preservative free15$491$33
Influenza vaccine, quadrivalent, 0.5 ml dosage13$215$17

2013: 4 services

Original Medicare services billed in 2013
Long return visit (40+ min)74$27,486$115
Return visit (30+ min)92$14,546$86
Administration of influenza virus vaccine30$802$27
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)24$208$9

Drugs they prescribed that Part D paid

$1,322,875

Pharmacies billed $1,322,875 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

1,276 generic and 1,000 brand-name prescriptions · $1,322,875 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Teriparatide82$274,724$3,350
Ozempic109$215,080$1,973
Mounjaro68$126,004$1,853
Trulicity50$95,246$1,905
Jardiance53$86,630$1,635
See all 44 drugs
Every Part D drug this clinician prescribed
Teriparatide82$274,724$3,350
Ozempic109$215,080$1,973
Mounjaro68$126,004$1,853
Trulicity50$95,246$1,905
Jardiance53$86,630$1,635
Tymlos14$62,795$4,485
Farxiga39$56,290$1,443
Tradjenta30$37,674$1,256
Rybelsus13$30,765$2,367
Lyumjev13$24,793$1,907
Tresiba Flextouch U-10034$19,516$574
Januvia11$18,053$1,641
Genotropin13$12,816$986
Tresiba Flextouch U-20018$12,518$695
Novolog Flexpen26$10,060$387
Lantus Solostar60$9,597$160
Humalog Kwikpen U-10020$7,757$388
Basaglar Kwikpen U-10017$7,615$448
Synthroid72$7,436$103
Levothyroxine353$5,074$14
Nano 2nd Gen Pen Needle52$5,065$97
Alendronate190$4,459$23
Metformin Hcl Er130$2,967$23
Ultra-Fine Mini Pen Needle23$2,462$107
Ultra-Fine Nano Pen Needle21$2,037$97
Ultra-Fine Short Pen Needle14$1,922$137
Atorvastatin103$1,677$16
Rosuvastatin58$1,440$25
Valsartan11$1,410$128
Hydrocortisone25$1,323$53
Calcitriol20$1,138$57
Risedronate14$801$57
Methimazole47$634$13
Metformin48$593$12
Levoxyl11$547$50
Glipizide Er17$468$28
Ezetimibe17$429$25
Pioglitazone19$411$22
Losartan49$403$8
Lisinopril35$233$7
Glipizide26$231$9
Chlorthalidone12$201$17
Amlodipine Besylate15$157$10
Hydrochlorothiazide18$117$6

Year by year

Part D prescribing by year
20242,417323None41%$1,322,875
20232,4023130% (0)45%$1,546,945
20222,3052990% (0)41%$1,372,033
20212,2762720% (0)42%$1,119,997
20202,2132280% (0)42%$1,047,012
20191,7732070% (0)42%$848,387
20181,5511830% (0)44%$747,569
20171,5981770% (0)45%$578,707
20161,8131700% (0)41%$607,252
20151,9211620% (0)40%$577,103
20141,7651480% (0)42%$360,463
20131,8801430% (0)43%$309,844

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 40 drugs

Part D drugs prescribed in 2023
Ozempic120$208,347$1,736
Trulicity91$200,955$2,208
Teriparatide38$136,509$3,592
Forteo22$106,324$4,833
Mounjaro57$102,253$1,794
Farxiga58$91,520$1,578
Jardiance59$90,689$1,537
Novolog Flexpen39$56,137$1,439
Lantus Solostar81$51,430$635
Tradjenta27$37,761$1,399
Humalog Kwikpen U-10025$32,954$1,318
Rybelsus15$29,372$1,958
Invokana16$29,259$1,829
Genotropin25$28,858$1,154
Januvia15$24,261$1,617
Tresiba Flextouch U-10035$23,499$671
Humalog13$20,236$1,557
Synthroid62$8,246$133
Baqsimi11$6,051$550
Levothyroxine311$5,783$19
Alendronate156$4,708$30
Ultra-Fine Nano Pen Needle30$4,060$135
Nano 2nd Gen Pen Needle44$3,670$83
Rosuvastatin62$3,313$53
Metformin Hcl Er121$2,950$24
Atorvastatin115$2,075$18
Ultra-Fine Mini Pen Needle16$2,051$128
Hydrocortisone20$1,732$87
Pioglitazone15$1,518$101
Calcitriol20$1,330$66
Glipizide Er14$990$71
Metformin57$812$14
Methimazole45$801$18
Lisinopril50$488$10
Losartan39$433$11
Ezetimibe13$326$25
Glipizide22$277$13
Amlodipine Besylate24$228$9
Levoxyl12$143$12
Hydrochlorothiazide14$66$5

2022: 42 drugs

Part D drugs prescribed in 2022
Ozempic116$217,997$1,879
Trulicity81$164,624$2,032
Tymlos27$112,943$4,183
Forteo16$92,518$5,782
Novolog Flexpen44$92,299$2,098
Jardiance50$84,521$1,690
Farxiga52$73,908$1,421
Lantus Solostar87$55,390$637
Teriparatide14$45,215$3,230
Mounjaro20$39,417$1,971
Januvia29$37,821$1,304
Humalog Kwikpen U-10016$28,750$1,797
Tradjenta19$24,605$1,295
Humalog23$23,993$1,043
Tresiba Flextouch U-10033$23,573$714
Invokana11$19,944$1,813
Genotropin13$11,361$874
Levothyroxine301$6,187$21
Synthroid49$6,048$123
Nano 2nd Gen Pen Needle39$4,736$121
Alendronate113$4,597$41
Basaglar Kwikpen U-10011$4,572$416
Ultra-Fine Nano Pen Needle38$3,676$97
Metformin Hcl Er151$3,249$22
Ultra-Fine Short Pen Needle12$2,509$209
Rosuvastatin41$2,064$50
Atorvastatin134$1,843$14
Hydrocortisone20$1,237$62
Pioglitazone22$1,228$56
Fenofibrate12$1,050$87
Calcitriol20$1,008$50
Easy Comfort Insulin11$909$83
Metformin57$881$15
Glipizide Er13$614$47
Methimazole46$610$13
Losartan47$541$12
Lisinopril49$502$10
Amlodipine Besylate44$488$11
Easy Touch Pen Needle12$429$36
Hydrochlorothiazide21$273$13
Carvedilol14$182$13
Glipizide20$177$9

2021: 41 drugs

Part D drugs prescribed in 2021
Ozempic110$196,030$1,782
Trulicity77$116,871$1,518
Novolog Flexpen57$101,209$1,776
Tymlos37$92,897$2,511
Lantus Solostar99$62,701$633
Jardiance49$61,175$1,248
Farxiga36$54,634$1,518
Humalog Kwikpen U-10022$37,814$1,719
Januvia25$31,863$1,275
Humalog31$30,899$997
Tresiba Flextouch U-10031$21,978$709
Tradjenta12$15,342$1,279
Novolog Mix 70-30 Flexpen11$13,710$1,246
Genotropin14$11,912$851
Synthroid54$7,048$131
Levothyroxine269$6,546$24
Onglyza11$5,350$486
Nano 2nd Gen Pen Needle26$3,135$121
Ultra-Fine Nano Pen Needle41$2,987$73
Ultra-Fine Mini Pen Needle22$2,983$136
Metformin Hcl Er135$2,732$20
Ultra-Fine Short Pen Needle11$2,010$183
Rosuvastatin39$1,929$49
Atorvastatin149$1,921$13
Fenofibrate17$1,456$86
Hydrocortisone20$1,242$62
Metformin63$969$15
Pioglitazone28$907$32
Glipizide49$769$16
Calcitriol13$726$56
Alendronate59$724$12
Losartan40$592$15
Methimazole40$569$14
Amlodipine Besylate59$517$9
Lisinopril62$493$8
Glipizide Er14$398$28
Losartan-Hydrochlorothiazide12$337$28
Carvedilol24$328$14
Atenolol14$128$9
Glimepiride13$96$7
Hydrochlorothiazide16$96$6

2020: 43 drugs

Part D drugs prescribed in 2020
Forteo17$115,028$6,766
Novolog Flexpen71$109,625$1,544
Trulicity68$90,448$1,330
Ozempic37$80,616$2,179
Glumetza11$70,276$6,389
Lantus Solostar109$67,475$619
Victoza 3-Pak30$54,106$1,804
Humalog41$48,831$1,191
Humalog Kwikpen U-10027$41,605$1,541
Januvia30$35,796$1,193
Jardiance25$22,801$912
Tresiba Flextouch U-10043$22,618$526
Genotropin14$12,064$862
Novolog Mix 70-30 Flexpen16$11,128$695
Levothyroxine241$6,124$25
Synthroid56$5,963$106
Ultra-Fine Nano Pen Needle61$5,955$98
Onglyza13$5,935$457
Humulin 70-3014$4,204$300
Metformin Hcl Er115$2,818$25
Atorvastatin133$2,601$20
Rosuvastatin52$2,580$50
Ultra-Fine Mini Pen Needle19$2,196$116
Fenofibrate21$1,967$94
Ultra-Fine Short Pen Needle14$1,478$106
Nano 2nd Gen Pen Needle12$1,381$115
Pioglitazone29$1,224$42
Hydrocortisone23$1,172$51
Liothyronine16$975$61
Alendronate62$960$15
Glipizide61$909$15
Metformin51$739$14
Metoprolol13$595$46
Losartan32$582$18
Lisinopril79$579$7
Glipizide Er16$467$29
Pravastatin15$455$30
Amlodipine Besylate55$420$8
Methimazole25$374$15
Carvedilol32$372$12
Simvastatin14$296$21
Losartan-Hydrochlorothiazide14$286$20
Hydrochlorothiazide17$100$6

2019: 41 drugs

Part D drugs prescribed in 2019
Forteo34$208,839$6,142
Novolog Flexpen53$87,379$1,649
Victoza 3-Pak45$70,291$1,562
Lantus Solostar92$53,934$586
Januvia37$46,309$1,252
Trulicity28$39,251$1,402
Humalog Kwikpen U-10031$35,847$1,156
Humalog30$32,195$1,073
Ozempic20$32,013$1,601
Tradjenta14$15,584$1,113
Lantus12$13,504$1,125
Jardiance15$9,669$645
Novolog Mix 70-30 Flexpen17$9,351$550
Tresiba Flextouch U-10013$6,383$491
Onglyza12$5,277$440
Ultra-Fine Nano Pen Needle50$5,197$104
Levothyroxine168$4,478$27
Tirosint16$3,916$245
Rosuvastatin43$3,452$80
Synthroid36$2,953$82
Atorvastatin87$2,349$27
Metformin Hcl Er108$2,349$22
Ultra-Fine Mini Pen Needle25$1,930$77
Ultra-Fine Short Pen Needle12$1,164$97
Metoprolol15$1,067$71
Pioglitazone26$1,006$39
Fenofibrate15$940$63
Hydrocortisone11$778$71
Metformin57$663$12
Glipizide60$626$10
Methimazole20$568$28
Glipizide Er14$515$37
Alendronate32$492$15
Lisinopril59$394$7
Testosterone Cypionate11$383$35
Amlodipine Besylate49$337$7
Losartan21$302$14
Glimepiride14$280$20
Losartan-Hydrochlorothiazide12$271$23
Carvedilol15$236$16
Hydrochlorothiazide11$56$5

2018: 35 drugs

Part D drugs prescribed in 2018
Forteo42$252,520$6,012
Novolog Flexpen30$60,726$2,024
Lantus Solostar70$43,258$618
Victoza 3-Pak25$39,645$1,586
Humalog Kwikpen U-10036$36,435$1,012
Humalog36$36,291$1,008
Januvia33$28,237$856
Trulicity20$23,634$1,182
Lantus31$22,734$733
Invokana20$17,178$859
Genotropin12$11,425$952
Humalog Mix 75-25 Kwikpen11$7,786$708
Novolog Mix 70-30 Flexpen14$7,520$537
Onglyza12$5,116$426
Ultra-Fine Nano Pen Needle54$5,109$95
Levothyroxine154$3,718$24
Tirosint28$3,609$129
Rosuvastatin30$3,019$101
Synthroid44$2,792$63
Ultra-Fine Mini Pen Needle19$2,023$106
Atorvastatin87$1,741$20
Metformin Hcl Er77$1,295$17
Pravastatin18$926$51
Pioglitazone27$781$29
Ezetimibe11$614$56
Glipizide60$596$10
Metformin52$590$11
Alendronate38$524$14
Metoprolol11$415$38
Methimazole17$340$20
Lisinopril46$304$7
Amlodipine Besylate35$251$7
Glimepiride11$190$17
Losartan25$146$6
Ramipril11$103$9

2017: 40 drugs

Part D drugs prescribed in 2017
Forteo28$102,507$3,661
Lantus Solostar97$73,046$753
Novolog Flexpen36$59,561$1,654
Victoza 3-Pak35$46,923$1,341
Humalog Kwikpen U-10044$37,921$862
Humalog46$33,266$723
Januvia28$26,057$931
Invokana25$19,053$762
Lantus22$14,992$681
Novolog Mix 70-30 Flexpen18$14,229$791
Trulicity12$12,078$1,007
Tradjenta18$11,765$654
Genotropin12$9,073$756
Onglyza13$4,666$359
Ultra-Fine Nano Pen Needle45$4,443$99
Synthroid77$3,678$48
Levothyroxine143$3,647$26
Novolog12$3,379$282
Atorvastatin91$2,433$27
Tirosint14$2,311$165
Bd Ultra-Fine Pen Needle23$2,097$91
Calcitriol11$2,090$190
Raloxifene11$1,904$173
Pioglitazone42$1,367$33
Ultra-Fine Mini Pen Needle18$1,290$72
Metformin Hcl Er60$1,145$19
Insulin25$1,141$46
Pravastatin14$744$53
Rosuvastatin16$657$41
Gabapentin15$581$39
Valsartan17$567$33
Glipizide73$549$8
Metformin56$509$9
Alendronate31$357$12
Lisinopril43$282$7
Methimazole13$265$20
Carvedilol24$232$10
Amlodipine Besylate24$170$7
Simvastatin16$156$10
Ramipril14$146$10

2016: 43 drugs

Part D drugs prescribed in 2016
Forteo43$130,883$3,044
Lantus Solostar106$69,851$659
Novolog Flexpen42$56,990$1,357
Humalog Kwikpen U-10040$42,888$1,072
Januvia46$36,618$796
Humalog41$31,863$777
Novolog Mix 70-30 Flexpen27$22,569$836
Lantus32$19,574$612
Invokana26$19,099$735
Tradjenta25$15,255$610
Victoza 3-Pak14$14,380$1,027
Bd Ultra-Fine Pen Needle137$10,582$77
Novolog17$8,693$511
Humalog Mix 75-25 Kwikpen14$8,000$571
Crestor18$7,434$413
Onglyza11$4,699$427
Raloxifene13$3,966$305
Zetia13$3,959$305
Levothyroxine127$3,265$26
Synthroid63$3,085$49
Rosuvastatin15$2,842$189
Atorvastatin85$2,372$28
Calcitriol14$2,287$163
Tirosint14$1,514$108
Valsartan27$1,335$49
Pioglitazone49$1,136$23
Metformin86$1,061$12
Insulin27$1,051$39
Repaglinide12$997$83
Glipizide97$907$9
Metformin Hcl Er57$769$13
Pravastatin18$716$40
Losartan-Hydrochlorothiazide12$511$43
Gabapentin22$478$22
Methimazole44$422$10
Lisinopril51$298$6
Simvastatin25$289$12
Alendronate22$201$9
Amlodipine Besylate20$198$10
Atenolol12$145$12
Carvedilol19$131$7
Losartan18$96$5
Hydrochlorothiazide11$48$4

2015: 46 drugs

Part D drugs prescribed in 2015
Lantus Solostar113$63,508$562
Forteo19$62,133$3,270
Novolog Flexpen42$48,159$1,147
Januvia53$35,136$663
Humalog Kwikpen U-10043$30,191$702
Humalog30$28,590$953
Novolog Mix 70-30 Flexpen37$26,515$717
Novolog31$19,693$635
Apidra14$19,446$1,389
Lantus35$18,951$541
Victoza 3-Pak14$11,652$832
Crestor35$11,236$321
Tradjenta27$10,384$385
Bd Ultra-Fine Pen Needle128$9,415$74
Invokana18$7,993$444
Onglyza14$5,899$421
Welchol12$5,844$487
Raloxifene14$5,074$362
Levothyroxine177$4,338$25
Repaglinide26$4,210$162
Synthroid61$2,731$45
Pioglitazone53$2,473$47
Valsartan23$2,075$90
Niacin Er11$1,996$181
Atorvastatin47$1,375$29
Insulin33$1,199$36
Pravastatin62$1,147$19
Metformin Hcl Er52$1,134$22
Glipizide102$925$9
Metformin66$789$12
Methimazole37$565$15
Quinapril12$431$36
Prednisone11$371$34
Lisinopril44$327$7
Hydrocortisone11$261$24
Alendronate24$246$10
Losartan34$235$7
Gabapentin18$229$13
Simvastatin22$204$9
Amlodipine Besylate21$181$9
Atenolol28$157$6
Lovastatin13$138$11
Carvedilol13$106$8
Hydrochlorothiazide35$101$3
Glimepiride12$95$8
Ramipril12$66$6

2014: 34 drugs

Part D drugs prescribed in 2014
Humalog89$49,236$553
Lantus Solostar99$40,408$408
Novolog Flexpen49$33,049$674
Januvia49$30,699$627
Novolog Mix 70-30 Flexpen35$23,474$671
Lantus52$21,556$415
Apidra12$14,446$1,204
Novolog12$11,294$941
Crestor32$8,744$273
Bd Ultra-Fine Pen Needle132$8,515$65
Victoza 3-Pak14$8,025$573
Repaglinide26$5,527$213
Levothyroxine205$3,763$18
Pioglitazone53$3,017$57
Synthroid68$2,442$36
Fenofibrate14$1,206$86
Metformin57$938$16
Pravastatin50$838$17
Metformin Hcl Er45$809$18
Atorvastatin42$754$18
Glipizide59$726$12
Insulin13$579$45
Quinapril12$545$45
Methimazole32$491$15
Gabapentin19$467$25
Simvastatin52$427$8
Glyburide15$329$22
Losartan20$326$16
Lisinopril47$274$6
Alendronate31$242$8
Lovastatin13$205$16
Amlodipine Besylate17$152$9
Hydrochlorothiazide29$142$5
Atenolol17$120$7

2013: 45 drugs

Part D drugs prescribed in 2013
Novolog Flexpen72$30,471$423
Lantus Solostar95$30,450$321
Humalog66$28,716$435
Januvia57$27,555$483
Novolog Mix 70-30 Flexpen35$19,671$562
Lantus57$16,018$281
Byetta27$12,166$451
Symlinpen 12011$11,348$1,032
Victoza 3-Pak18$11,289$627
Apidra14$11,049$789
Novolog19$9,914$522
Bd Ultra-Fine Pen Needle152$8,267$54
Pioglitazone41$5,734$140
Prandin15$5,609$374
Crestor17$4,571$269
Humulin R11$3,462$315
Evista12$3,412$284
Benicar17$2,660$156
Fenofibrate27$2,277$84
Metformin Hcl Er29$2,106$73
Levothyroxine175$2,101$12
Synthroid50$1,613$32
Metformin93$1,508$16
Atorvastatin44$1,395$32
Glyburide40$1,045$26
Insulin17$851$50
Pravastatin58$848$15
Glipizide59$736$12
Gabapentin26$734$28
Methimazole41$717$17
Losartan40$668$17
Lovastatin31$639$21
Simvastatin59$626$11
Insulin17$586$34
Glipizide Xl12$554$46
Propylthiouracil12$540$45
Hydralazine11$327$30
Lisinopril43$290$7
Quinapril12$282$23
Alendronate25$271$11
Amlodipine Besylate28$261$9
Prednisone11$170$15
Atenolol12$147$12
Carvedilol13$104$8
Hydrochlorothiazide26$90$3

Professional record

NPI
1871552679
Licence
CA A86467California A86467: Current · expires 2027-10-31
Trained
University of Michigan Medical School, 1999
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
Mailing address
5800 Hollis St, Emeryville, CA, 94608
NPI first listed
2006-03-21
NPI last updated
2024-04-29
NPI record certified
2024-04-29

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr, Palo Alto, CA, 94304